Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
D. Feyaerts, J. Hedou, J. Gillard, H. Chen, E. S. Tsai, L. S. Peterson, K. Ando, M. Manohar, E. Do, G. K. R. Dhondalay, J. Fitzpatrick, M. Artandi, I. Chang, T. T. Snow, R. S. Chinthrajah, , D. R. McIlwain
This study integrates plasma proteomics and single-cell immune features to classify COVID-19 severity and identify biological signatures of disease progression.
bioRxiv · Feb 9, 2021Immunology